Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Industry Analysis, Growth, Trends and Forecast – 2028

The Recombinant Deoxyribonucleic Acid (rDNA) Technology Market size is expected to grow at an annual average of CAGR 5% during the forecast period (2022-2028). Recombinant DNA (rDNA) technology has given scientists unprecedented control over their genetic material. It has expanded its use in a wide range of applications, including both traditional and non-traditional applications. Over the past few years, the space has made tremendous strides in producing recombinant drugs and therapeutics without the help of human donors.

 

A classic example of this achievement is the commercial success of genetically engineered insulin for the treatment of diabetes. Biotechnology and pharmaceutical companies are involved in unlocking the potential of rDNA technology in various aspects of disease management. This is primarily to avoid the burgeoning burden of chronic disease and keep pace with the growing demand for treatment.

The following segmentation are covered in this report:

By End User

• Biotechnology and Pharmaceutical Companies
• Academic and Government Research Institutes
• Other End Users

By Application

• Food and Agriculture
• Health and Disease
• Environment
• Other Applications

By Component

• Expression System
• Cloning Vector

Company Profile

• Amgen Inc.
• Eli Lilly and Company
• Hoffmann-La Roche Ltd (Genentech Inc.)
• GenScript
• Horizon Discovery
• Merck KGaA
• New England Biolabs
• Novartis AG
• Novo Nordisk A/S
• Pfizer Inc.
• Sanofi
• Syngene International Limited

Scope of the report

The research study analyses the Recombinant Deoxyribonucleic Acid (rDNA) Technology Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North America market size and/or volume
• Latin America market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Recombinant Deoxyribonucleic Acid (rDNA) Technology Market Report

• What was the Recombinant Deoxyribonucleic Acid (rDNA) Technology Market size in 2022 and 2028; what are the estimated growth trends and market forecast (2022-2028)
• What will be the Recombinant Deoxyribonucleic Acid (rDNA) Technology Market CAGR of Market during the forecast period (2022-2028)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
• Which manufacturer/vendor/players in the Recombinant Deoxyribonucleic Acid (rDNA) Technology Market was the market leader in 2022?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.